Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 3/2014

Open Access 01-05-2014 | Oral presentation

Role of myeloid derived suppressor cells in tuberculosis infection and disease

Authors: Nathella Pavan Kumar, Rathinam Sridhar, Vaithilingam V Banurekha, Mohideen S Jawahar, Thomas B Nutman, Subash Babu

Published in: BMC Infectious Diseases | Special Issue 3/2014

Login to get access

Excerpt

Mycobacterium tuberculosis infects 2 billion people worldwide, 90% of infected individuals are able to resist overt disease development and manifest only latent infection. Myeloid derived suppressor cells (MDSCs) are a heterogeneous population of early myeloid progenitors, immature granulocytes, macrophages, and dendritic cells at different stages of differentiation. These cells have the capacity to suppress activities of adaptive immune response mediated by CD4+ and CD8+ T cells. …
Metadata
Title
Role of myeloid derived suppressor cells in tuberculosis infection and disease
Authors
Nathella Pavan Kumar
Rathinam Sridhar
Vaithilingam V Banurekha
Mohideen S Jawahar
Thomas B Nutman
Subash Babu
Publication date
01-05-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue Special Issue 3/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-S3-O18

Other articles of this Special Issue 3/2014

BMC Infectious Diseases 3/2014 Go to the issue

ePoster presentation

HbAHP-25, a peptide designed in silico, exhibits potent anti-HIV activity in vitro

Oral presentation

Experimental mouse model of tuberculous uveitis

Poster presentation

Causes of prolonged fever among HIV infected patients- utility of an algorithmic approach - a single centre study from south India

Poster presentation

The length of stay and the hospital cost for ICU patients with resistant bacterial infections: a pilot study

ePoster presentation

Feasibility of a Short Message Service based intervention to improve adherence among HIV-positive youth in Uganda: a focus group study

Oral presentation

Application of Real Time loop mediated isothermal amplification (RT LAMP) as a point of care assay using dried blood spots for rapid detection of HIV infection
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits